6/20/2018 | BKCVDDEMIGPV | Market Commentary: Intelsat dominates trading; PHI recoups losses; Valeant Pharmaceuticals active
|
5/25/2018 | BKCVDDEMIGPV | Market Commentary: Primary market quiet pre-holiday; forward calendar light; California Resources in focus
|
5/21/2018 | BKCVDDEMIGPV | Market Commentary: Graham Holdings, Atotech on tap; Ithaca Energy, JW Aluminum delayed; EP Energy dominates
|
5/18/2018 | BKCVDDEMIGPV | Market Commentary: EP Energy, BWX prices; Valeant trades up; Hearthside, SRS struggle; Sprint tanks
|
5/17/2018 | BKCVDDEMIGPV | Market Commentary: Valeant, Hearthside, SRS, others price; GFL, WeWork struggle again; funds lose $542 million
|
5/10/2018 | BKCVDDEMIGPV | Market Commentary: Nemaska prices; Hearthside, Valeant join calendar; MDC tanks; funds add $0.76 billion
|
5/8/2018 | BKCVDDEMIGPV | Market Commentary: Primary quiet; Gaming & Leisure active; Dish volatile; Sanchez Energy drops, Valeant gains
|
3/16/2018 | BKCVDDEMIGPV | Market Commentary: Tullow, Husky lead busy primary; Mattel trades on Toys shutdown; Teva still trades under par
|
3/15/2018 | BKCVDDEMIGPV | Market Commentary: Live Nation, Aker price new deals; new Guitar Center active; funds gain $11 million
|
3/14/2018 | BKCVDDEMIGPV | Market Commentary: Guitar Center, NVA bring deals; U.S. Steel, J.C. Penney dominate secondary; Valeant busy
|
3/13/2018 | BKCVDDEMIGPV | Market Commentary: U.S. Steel prices $650 million; new Valeant dominates secondary; recent Frontier active
|
3/12/2018 | BKCVDDEMIGPV | Market Commentary: Valeant, American Axle price; Frontier, J.C. Penney new issues continue activity
|
2/28/2018 | BKCVDDEMIGPV | Market Commentary: Warner Music, Kennedy-Wilson add-on price; Sprint continues to dominate secondary
|
1/5/2018 | BKCVDDEMIGPV | Market Commentary: Primary quiet as junk closes year’s first week, pick up expected; oil names ease
|
1/2/2018 | BKCVDDEMIGPV | Market Commentary: Junk primary quiet as 2018 opens; CalRes rises with crude; Chesapeake up with gas prices
|
12/22/2017 | BKCVDDEMIGPV | Market Commentary: Junk quiet pre-holiday; Medical Properties Trust off, Valeant up; Kindred ends week up
|
12/21/2017 | BKCVDDEMIGPV | Market Commentary: Primary quiet as holiday nears; CalRes, Valeant, Mattel up; funds lose $1.11 billion
|
12/12/2017 | BKCVDDEMIGPV | Market Commentary: Upsized Whiting megadeal, Iron Mountain lead $2.63 billion day; more PetSmart punishment
|
12/11/2017 | BKCVDDEMIGPV | Market Commentary: NFP prices add-on; Standard does a split-rate; recent Valeant again firms; Algeco up
|
12/8/2017 | BKCVDDEMIGPV | Market Commentary: ACE Cash, Itron, revamped BMC close $11.2 billion primary week; new Jeld-Wen busy
|
12/6/2017 | BKCVDDEMIGPV | Market Commentary: Primary pace slackens as Mercer brings sole dollar deal; Claire’s climbs on results
|
12/5/2017 | BKCVDDEMIGPV | Market Commentary: Quicken megadeal paces second straight $3.5 billion day; heavy trading in new Valeant
|
12/4/2017 | BKCVDDEMIGPV | Market Commentary: Valeant, Continental Resources megadeals lead $3.5 billion session; energy surges
|
11/15/2017 | BKCVDDEMIGPV | Market Commentary: Centennial is lone pricing as primary calms down; Murray slides as Bowie buyout dies
|
11/14/2017 | BKCVDDEMIGPV | Market Commentary: Lennar megadeal, Valeant add-on pace $3.8 billion primary day; energy names off
|
11/13/2017 | BKCVDDEMIGPV | Market Commentary: Resolute deal on, then off; Valeant shops add-on; Rite Aid firms; market weakens
|
11/7/2017 | BKCVDDEMIGPV | Market Commentary: Primary quiets, but Michael Baker slates deal; new QEP steady; Windstream falls; oils jump
|
10/3/2017 | BKCVDDEMIGPV | Market Commentary: Downsized West, upsized Energy Transfer and PBF add-on price; existing Valeants fall
|
10/2/2017 | BKCVDDEMIGPV | Market Commentary: Crown Rock, Valeant, Scientific Games drive by; new Caesars notes busy, Murray up
|
9/29/2017 | BKCVDDEMIGPV | Market Commentary: Caesars prices $1.7 billion, gains in trading; Jonah stays firm; Valeant up on asset sale
|
9/25/2017 | BKBWCVDDHY | Valeant may lower ‘hefty’ debt through equity-linked securities sale
|
8/9/2017 | BKCVDDEMIGPV | Market Commentary: TMS Int’l, David Weekly, Clear Channel Outdoor price; Hertz higher, Valeant gives up gains
|
8/8/2017 | BKCVDDEMIGPV | Market Commentary: Upsized Restaurant Brands megadeal, Triumph and WPX price; new Dynegy busy; Valeant jumps
|
7/17/2017 | BKCVDDEMIGPV | Market Commentary: Lithia prices, rises; new Hovnanians continue climb; Valeant firms on asset-sale news
|
6/22/2017 | BKCVDDEMIGPV | Market Commentary: J2 prices; Senate bill drives health higher; Rite Aid lower on report; funds out $128 million
|
6/9/2017 | BKCVDDEMIGPV | Market Commentary: Navient add-on caps nearly $6 billion week; new HCA firms; Rite Aid slide continues
|
6/8/2017 | BKCVDDEMIGPV | Market Commentary: HCA split-rated deal prices; recent issues easier; Valeant up on asset sale; funds gain
|
5/1/2017 | BKCVDDEMIGPV | Market Commentary: USG, New Home drive by; Covey Park active; Pharmaceutical Product about flat; Petsmart up
|
4/18/2017 | BKCVDDEMIGPV | Market Commentary: Cumberland prices; Petsmart surges after Chewy acquisition; Post up a bit; pharma down
|
4/12/2017 | BKCVDDEMIGPV | Market Commentary: SNF Floerger, Tutor Perini, Endo, Tennant price; Toys ‘R’ Us jumps; recent issues mixed
|
3/21/2017 | BKCVDDEMIGPV | Market Commentary: Valeant down on lower session; Petsmart follows; recent First Quantum and AK Steel fall
|
3/15/2017 | BKCVDDEMIGPV | Market Commentary: Eldorado prices, firms; Foresight, Quantum deals on tap; market firms after Fed rate move
|
3/14/2017 | BKCVDDEMIGPV | Market Commentary: Primaryside focus turned to Europe; new T-Mobile, AMC deals active; new Valeant retreats
|
3/13/2017 | BKCVDDEMIGPV | Market Commentary: T-Mobile three-part megadeal, AMC drive by, new AMC gains; new Valeant again firm
|
3/10/2017 | BKCVDDEMIGPV | Market Commentary: New Home, Fortress price to cap $17.54 billion week, biggest of all time, recent deals busy
|
3/9/2017 | BKCVDDEMIGPV | Market Commentary: Valeant, American Axle, Charter lead year’s biggest day so far; funds plunge $2.12 billion
|
3/6/2017 | BKCVDDEMIGPV | Market Commentary: Aircastle, Olin, Vermilion price; calendar swells; new Blue Line, CyrusOne busy
|
3/1/2017 | BKCVDDEMIGPV | Market Commentary: Dollar pricings again absent, but BlueLine, Vermilion slate; Avis prices euro deal
|
2/28/2017 | BKCVDDEMIGPV | Market Commentary: Dollar primary still on hold, Stonegate to shop sterling deal; Intelsat adds to gains
|
1/11/2017 | BKCVDDEMIGPV | Market Commentary: Novalex prices; Team Health ahead; Valeant down; other pharma companies follow; E&P mixed
|
1/10/2017 | BKCVDDEMIGPV | Market Commentary: Novolex on tap, Icahn on the road; Sabine Pass up on ratings boost, Valeant on asset sale
|
12/13/2016 | BKCVDDEMIGPV | Market Commentary: Upsized AmeriGas, Concho, American Midstream price; recent RSP Permian, Carlson trade up
|
11/23/2016 | BKCVDDEMIGPV | Market Commentary: Firmer junk market quietly heads into holiday break; Conduent paper well above issue price
|
11/8/2016 | BKCVDDEMIGPV | Market Commentary: Primary stays quiet, Telesat Canada downsizes, CF deal seen high-grade; Valeant, Hertz dip
|
11/3/2016 | BKCVDDEMIGPV | Market Commentary: Downsized ServiceMaster prices, also Associated Materials, Kissner; funds dive by $4 billion-plus
|
11/2/2016 | BKCVDDEMIGPV | Market Commentary: Dollar primary quiets down after huge session; Telesat slates; Tutor Perini spikes deal
|
8/11/2016 | BKCVDDEMIGPV | Market Commentary: XPO, Service King drive by, XPO gains; Community Health, Valeant lower; funds add $1.655 billion
|
8/10/2016 | BKCVDDEMIGPV | Market Commentary: No dollar deals price, Murphy Oil slates; new MGM Growth, Builders, Veritas issues active
|
8/9/2016 | BKCVDDEMIGPV | Market Commentary: Builders First Source leads drive-by parade, new bonds pop; Valeant jumps on results
|
7/8/2016 | BKCVDDEMIGPV | Market Commentary: New Transocean notes busy, better; primary quiet but hopeful; overall junk market stronger
|
6/7/2016 | BKCVDDEMIGPV | Market Commentary: Gray TV, Six Flags drive by, Zekelman also prices, new bonds busy, higher; Valeant gyrates
|
5/27/2016 | BKCVDDEMIGPV | Market Commentary: Primary quiet to end $11 billion week; Yum! slates megadeal; Valeant up on M&A buzz
|
5/3/2016 | BKCVHY | Moody’s lifts Valeant probability rating
|
5/3/2016 | BKCVHY | S&P: Valeant on positive watch
|
4/29/2016 | BKCVDDEMIGPV | Market Commentary: Ardagh brings $4.5 billion to strong demand; Western Digital off post-earnings; Valeant pressured
|
4/14/2016 | BKCVHY | S&P downgrades Valeant
|
4/7/2016 | BKCVDDEMIGPV | Market Commentary: Upsized Charter drives by, eases; new Numericable again tops actives; funds gain $1.18 billion
|
4/5/2016 | BKCVDDEMIGPV | Market Commentary: Downsized Diebold prices; new Sunoco still struggles; WDC busy again; Valeant bonds bounce
|
3/21/2016 | BKCVDDEMIGPV | Market Commentary: Intelsat, Aircastle price upsized drive-by deals; Valeant bonds busy amid board turmoil
|
3/18/2016 | BKCVDDEMIGPV | Market Commentary: Upsized MDC prices to cap $2.57 billion week, moves up; oil names gain; busy Valeant fades
|
3/16/2016 | BKCVDDEMIGPV | Market Commentary: Cinemark brings add-on; Kraton Polymers relaunches deal; Radian up; Valeant again active
|
3/15/2016 | BKCVDDEMIGPV | Market Commentary: Radian prices, new bonds pop, recent deals steady; Valeant down on warning, lower guidance
|
3/1/2016 | BKCVDDEMIGPV | Market Commentary: Upsized HCA megadeal drives by, bonds rise; new Solera strong; Valeant rebounds
|
2/29/2016 | BKCVDDEMIGPV | Market Commentary: Restructured Solera deal prices; new Lennar busy; Valeant dives on SEC probe, Intelsat off
|
2/23/2016 | BKCVDDEMIGPV | Market Commentary: Summit Materials drives by; Solera sets talk; Valeant rebounds, but Intelsat slide worsens
|
1/7/2016 | BKCVDDEMIGPV | Market Commentary: Microsemi brings year’s first syndicated new deal; market lower, funds lose $809 million
|
1/5/2016 | BKCVDDEMIGPV | Market Commentary: Junk steadies after opening 2016 with loss; Chesapeake gains, primary calm, but M&A deals expected
|
12/22/2015 | BKCVDDEMIGPV | Market Commentary: Junk sees improved tone, helped by better stocks, oil prices; Valeant up; Denbury down
|
12/17/2015 | BKCVDDEMIGPV | Market Commentary: Two-day junk rally ends; oils lower; Valeant mixed, Navistar up; funds plunge $3.81 billion
|
12/16/2015 | BKCVDDEMIGPV | Market Commentary: Junk rally continues as Fed hikes rates, primary remains quiet; Valeant extends gains
|
12/15/2015 | BKCVDDEMIGPV | Market Commentary: Primary still quiet as junk turns broadly higher; Valeant jumps on Walgreens arrangement
|
11/10/2015 | BKCVDDEMIGPV | Market Commentary: Teekay, ContourGlobal bring add-ons in quiet pre-holiday session; Valeant firms after call
|
11/9/2015 | BKCVDDEMIGPV | Market Commentary: HCA megadeal prices, trades actively; Team Health, ContourGlobal slate; market moves lower
|
11/3/2015 | BKCVDDEMIGPV | Market Commentary: CNH, Platform Specialty Products price; Platform pops; new T-Mobile jumps on heavy volume
|
10/30/2015 | BKCVDDEMIGPV | Market Commentary: Primary quiet to close out $6 billion week, $9.4 billion month; Thursday deals rise in heavy trading
|
10/28/2015 | BKCVDDEMIGPV | Market Commentary: Primary quiet, but new L Brands bonds jump; Bombardier flies on government aid report
|
10/27/2015 | BKCVDDEMIGPV | Market Commentary: L Brands, Toll drive by; Rite Aid jumps on Walgreens buyout news; Valeant bonds turn mixed
|
10/26/2015 | BKCVDDEMIGPV | Market Commentary: Valeant bonds fall despite company’s presentation; Chesapeake chopped on gas price weakness
|
10/23/2015 | BKCVDDEMIGPV | Market Commentary: Pharmaceutical, hospital names rebound; Asbury add-on closes $1.65 billion primary week
|
10/22/2015 | BKCVDDEMIGPV | Market Commentary: Hospital names fall on Community Health earnings warning; funds see $3.34 billion inflow
|
10/21/2015 | BKCVDDEMIGPV | Market Commentary: Valeant crushed as short-seller’s report alleges fraud; Jarden prices; Globo postpones
|
10/19/2015 | BKCVDDEMIGPV | Market Commentary: Primary quiet, though American Energy – Permian on tap; new AerCap keeps firming in active trading
|
10/16/2015 | BKCVDDEMIGPV | Market Commentary: AerCap parachutes in with upsized $1 billion deal, new bonds fly; Valeant, oils, Wynn all rebound
|
10/15/2015 | BKCVDDEMIGPV | Market Commentary: Valeant sours on subpoena, Fortescue up on debt buyback, cost cuts; funds gain $1.48 billion in week
|
10/5/2015 | BKCVDDEMIGPV | Market Commentary: High yield rebounds as week begins; Valeant paper fades; Cablevision, Altice climb higher
|
9/29/2015 | BKCVDDEMIGPV | Market Commentary: Valeant rebounds; Alcoa ends weak again; Chesapeake announces layoffs; Bombardier firms
|
9/28/2015 | BKCVDDEMIGPV | Market Commentary: High-yield market ends in ‘bloodbath’; recent new issues pressured; Valeant faces subpoena
|
8/20/2015 | BKCVDDEMIGPV | Market Commentary: No pricings, primary seen done for summer; new KIK, Oneok notes active; funds gain $111 million
|
6/25/2015 | BKCVDDEMIGPV | Market Commentary: TI Automotive prices; Endo deal adds to gains; Valeant off on M&A; funds up $621 million
|
4/9/2015 | BKCVDDEMIGPV | Market Commentary: Fiat Chrysler, Murray deals lead $6.6 billion primary; Halcon up; funds gain $1.35 billion
|
4/2/2015 | CV | Moody’s drops Sound Global, debt
|
4/2/2015 | BKCVHY | S&P lifts Valeant secured debt
|
4/1/2015 | CVLM | Salix convertible noteholders get change-of-control put option
|
3/18/2015 | BKCVDDEMIGPV | Market Commentary: Infor megadeal prices; Rite Aid, Huntsman slate; still-accommodative Fed helps market firm
|
3/17/2015 | BKCVDDEMIGPV | Market Commentary: Virgin Media, split-rated Masco deals price, Fortescue shelves offering; energy fades more
|
3/16/2015 | BKCVDDEMIGPV | Market Commentary: Vulcan drives by; new Valeant bonds busy as Endo gives up on Salix; energy slide continues
|
3/13/2015 | BKCVDDEMIGPV | Market Commentary: Giant-sized Valeant deal caps nearly $16 billion week, new bonds busy; energy names slide
|
3/12/2015 | BKCVDDEMIGPV | Market Commentary: United Rentals two-parter, CenturyLink price; Valeant upsizes; funds lose $1.96 billion
|
3/11/2015 | BKCVDDEMIGPV | Market Commentary: Shea Homes two-parter, Surgical Care, GFL deals price; Valeant up on Endo bid for Salix
|
3/9/2015 | BKCVDDEMIGPV | Market Commentary: Crestwood, Masonite, HealthSouth drive by; calendar builds; Whiting jumps on sale talk
|
2/24/2015 | BKCVDDEMIGPV | Market Commentary: Digicel drives by, moves up; recent bonds busy; Sitel bonds gain as Onex eyes possible sale
|
2/23/2015 | BKCVDDEMIGPV | Market Commentary: DISH weakens after numbers, CEO retirement; Salix gains on Valeant merger; Toys’ bonds up
|
1/20/2015 | BKCVDDEMIGPV | Market Commentary: Post-holiday primary cooks with Zayo, Endo, HealthSouth drive-bys; new, recent deals busy
|
1/15/2015 | BKCVDDEMIGPV | Market Commentary: Valeant, Targa price megadeals; Bombardier drops on plane pause; funds gain $879.5 million
|
6/18/2014 | BKCVDDEMIGPV | Market Commentary: West megadeal, NuvoTV, Wave Division offerings price; Valeant plans massive deal
|
1/22/2014 | CVHY | Valeant to redeem up to $1.5 billion of notes under repurchase program
|
12/5/2013 | BKCVHY | S&P rates Valeant loan BB
|
6/19/2013 | BKCVHY | S&P lowers Valeant, rates new term loans BB, notes B
|
6/19/2013 | BKCVHY | Moody's: Valeant notes B1, loans Ba1
|
1/17/2013 | BKCVHY | S&P rates Valeant loan BBB-
|
11/19/2012 | CVLM | Valeant buys back C$2.4 million 5.375% convertibles for C$7.9 million
|
6/5/2012 | BKCACVHY | S&P rates Valeant loan BBB-
|
1/30/2012 | BKCACVHY | Moody's rates Valeant loan Ba1
|
11/3/2011 | CACVHYLM | Valeant Pharmaceuticals reports double-digit growth, ends Q3 with $5.6 billion of debt
|
11/3/2011 | CACVHYLM | Valeant resumes buyback program for convertibles, notes and other debt
|
9/15/2011 | CACVHYLM | Valeant eyes growth in Europe; cash flow from operations could hit $900 million in 2012
|
8/29/2011 | CACVHYLM | Valeant increases securities repurchase program to C$1.8 billion
|
5/9/2011 | CVLM | Valeant buys back $63.8 million 5.375% convertibles in first quarter
|
4/20/2011 | CVLM | Valeant issues call to redeem all 4% convertible notes due 2013
|
3/31/2011 | CV | Market Commentary: Greenbrier expands on debut; Ramco-Gershenson to price; Dendreon in line on drug news
|
3/30/2011 | CV | Market Commentary: Cephalon comes in on hedge after Valeant bid; new InterDigital up; Greenbrier adds in gray
|
3/30/2011 | BKCACVHY | S&P puts Valeant on watch
|
3/30/2011 | BKCACVHY | Moody's may cut Valeant
|
2/28/2011 | CVLM | Valeant buys back $137.6 million of convertibles, 2.3 million shares
|
11/19/2010 | BKCACVHY | Moody's: Valeant unchanged
|
11/18/2010 | CV | Moody's rates Valeant notes B1
|
11/4/2010 | CACVHYLM | Valeant to buy back $1.5 billion convertibles, senior notes, stock
|